BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 26619808)

  • 21. Correlation of gene polymorphisms of CD36 and ApoE with susceptibility of Alzheimer disease: A case-control study.
    Zhou L; Li HY; Wang JH; Deng ZZ; Shan YL; Tan S; Shi YH; Zhang MX; Liu SX; Zhang BJ; Hong MF; Lu ZQ; Huang XM
    Medicine (Baltimore); 2018 Sep; 97(38):e12470. PubMed ID: 30235742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 4,752 C/T polymorphism in the presenilin 1 gene increases the risk of Alzheimer's disease in apolipoprotein E4 carriers.
    Matsubara-Tsutsui M; Yamagata H; Morishima A; Nakura J; Mitsuda N; Kamino K; Kondo I; Miki T
    Intern Med; 2002 Oct; 41(10):823-8. PubMed ID: 12413003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
    Belbin O; Beaumont H; Warden D; Smith AD; Kalsheker N; Morgan K
    Neurobiol Aging; 2009 Dec; 30(12):1992-9. PubMed ID: 18403054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOE Genotype and Nonrespiratory Sleep Parameters in Cognitively Intact Older Adults.
    Spira AP; An Y; Peng Y; Wu MN; Simonsick EM; Ferrucci L; Resnick SM
    Sleep; 2017 Aug; 40(8):. PubMed ID: 28482100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential Modifying Effect of the
    Valdez-Gaxiola CA; Maciel-Cruz EJ; Hernández-Peña R; Dumois-Petersen S; Rosales-Leycegui F; Gallegos-Arreola MP; Moreno-Ortiz JM; Figuera LE
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The APOE E4 Allele Confers Increased Risk of Ischemic Stroke Among Greek Carriers.
    Konialis C; Spengos K; Iliopoulos P; Karapanou S; Gialafos E; Hagnefelt B; Vemmos K; Zakopoulos N; Pangalos C
    Adv Clin Exp Med; 2016; 25(3):471-8. PubMed ID: 27629735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease.
    Combarros O; García-Román M; Fontalba A; Fernández-Luna JL; Llorca J; Infante J; Berciano J
    Dement Geriatr Cogn Disord; 2003; 15(3):151-4. PubMed ID: 12584430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Early-Onset Alzheimer Disease With Elevated Low-Density Lipoprotein Cholesterol Levels and Rare Genetic Coding Variants of APOB.
    Wingo TS; Cutler DJ; Wingo AP; Le NA; Rabinovici GD; Miller BL; Lah JJ; Levey AI
    JAMA Neurol; 2019 Jul; 76(7):809-817. PubMed ID: 31135820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective association of the ε2/ε3 heterozygote with Alzheimer's disease is strengthened by TOMM40-APOE variants in men.
    Kulminski AM; Philipp I; Loika Y; He L; Culminskaya I
    Alzheimers Dement; 2021 Nov; 17(11):1779-1787. PubMed ID: 34310032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12.
    Pericak-Vance MA; Bass MP; Yamaoka LH; Gaskell PC; Scott WK; Terwedow HA; Menold MM; Conneally PM; Small GW; Vance JM; Saunders AM; Roses AD; Haines JL
    JAMA; 1997 Oct; 278(15):1237-41. PubMed ID: 9333264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer's disease.
    Sepulveda-Falla D; Chavez-Gutierrez L; Portelius E; Vélez JI; Dujardin S; Barrera-Ocampo A; Dinkel F; Hagel C; Puig B; Mastronardi C; Lopera F; Hyman BT; Blennow K; Arcos-Burgos M; de Strooper B; Glatzel M
    Acta Neuropathol; 2021 Feb; 141(2):217-233. PubMed ID: 33319314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families.
    Houlden H; Crook R; Backhovens H; Prihar G; Baker M; Hutton M; Rossor M; Martin JJ; Van Broeckhoven C; Hardy J
    Am J Med Genet; 1998 Feb; 81(1):117-21. PubMed ID: 9514597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-ε4 carriers.
    Benitez BA; Karch CM; Cai Y; Jin SC; Cooper B; Carrell D; Bertelsen S; Chibnik L; Schneider JA; Bennett DA; ; ; Fagan AM; Holtzman D; Morris JC; Goate AM; Cruchaga C
    PLoS Genet; 2013; 9(8):e1003685. PubMed ID: 23990795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Apolipoprotein E4 and late-onset Alzheimer's disease].
    Tamaoka A
    Nihon Rinsho; 1994 Dec; 52(12):3257-65. PubMed ID: 7853720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between presenilin 1 intronic polymorphism and late onset Alzheimer's disease in the North Chinese population.
    Jia L; Zhou C; Lv H; Wang W; Ye J; Zhang X; Zhou W; Xu J; Wang L; Jia J
    Brain Res; 2006 Oct; 1116(1):201-5. PubMed ID: 16938285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Study of Alzheimer's Disease in Saudi Population.
    El Bitar F; Qadi N; Al Rajeh S; Majrashi A; Abdulaziz S; Majrashi N; Al Inizi M; Taher A; Al Tassan N
    J Alzheimers Dis; 2019; 67(1):231-242. PubMed ID: 30636737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presenilin E318G variant and Alzheimer's disease risk: the Cache County study.
    Hippen AA; Ebbert MT; Norton MC; Tschanz JT; Munger RG; Corcoran CD; Kauwe JS
    BMC Genomics; 2016 Jun; 17 Suppl 3(Suppl 3):438. PubMed ID: 27357204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of apolipoprotein genotype and educational attainment on cognitive function in autosomal dominant Alzheimer's disease.
    Langella S; Barksdale NG; Vasquez D; Aguillon D; Chen Y; Su Y; Acosta-Baena N; Acosta-Uribe J; Baena AY; Garcia-Ospina G; Giraldo-Chica M; Tirado V; Muñoz C; Ríos-Romenets S; Guzman-Martínez C; Oliveira G; Yang HS; Vila-Castelar C; Pruzin JJ; Ghisays V; Arboleda-Velasquez JF; Kosik KS; Reiman EM; Lopera F; Quiroz YT
    Nat Commun; 2023 Aug; 14(1):5120. PubMed ID: 37612284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Genetics of Early- and Late-Onset Alzheimer's Disease.
    Uddin MS; Hasana S; Hossain MF; Islam MS; Behl T; Perveen A; Hafeez A; Ashraf GM
    Curr Gene Ther; 2021; 21(1):43-52. PubMed ID: 33231156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that Abeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype.
    De Jonghe C; Cras P; Vanderstichele H; Cruts M; Vanderhoeven I; Smouts I; Vanmechelen E; Martin JJ; Hendriks L; Van Broeckhoven C
    Neurobiol Dis; 1999 Aug; 6(4):280-7. PubMed ID: 10448055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.